Literature DB >> 10595365

In vitro transport and delivery of antisense oligonucleotides.

J Hughes1, A Astriab, H Yoo, S Alahari, E Liang, D Sergueev, B R Shaw, R L Juliano.   

Abstract

A variety of techniques are currently available to enhance the cellular uptake and pharmacological effectiveness of antisense oligonucleotides in the in vitro setting. The choice of technique will depend on the context of investigation, the likelihood of cytotoxity due to the delivery agents, and the ease and convenience of the approach. The considerations for the delivery of antisense molecules in the in vivo setting are likely to be quite different from the cell culture situation emphasized in this article.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10595365     DOI: 10.1016/s0076-6879(00)13021-6

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  3 in total

1.  The spherulites(TM): a promising carrier for oligonucleotide delivery.

Authors:  N Mignet; A Brun; C Degert; B Delord; D Roux; C Hélène; R Laversanne; J C François
Journal:  Nucleic Acids Res       Date:  2000-08-15       Impact factor: 16.971

2.  Inhibition of translation by RNA-small molecule interactions.

Authors:  Isabelle Harvey; Philippe Garneau; Jerry Pelletier
Journal:  RNA       Date:  2002-04       Impact factor: 4.942

3.  Efficient siRNA transfection to the inner ear through the intact round window by a novel proteidic delivery technology in the chinchilla.

Authors:  W Qi; D Ding; H Zhu; D Lu; Y Wang; J Ding; W Yan; M Jia; Y Guo
Journal:  Gene Ther       Date:  2013-10-10       Impact factor: 5.250

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.